eQcell

Guelph, Canada Founded: 2010 • Age: 16 yrs
Stem cell therapies for animal health are developed.

About eQcell

eQcell is a company based in Guelph (Canada) founded in 2010. eQcell has raised $4.6 million across 3 funding rounds from investors including Ag Capital Canada and Accelerator Centre. The company has 8 employees. eQcell offers products and services including Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells. eQcell operates in a competitive market with competitors including Gallant, Bioceltix, Nupsala, J-ARM and Vetherapy, among others.

  • Headquarter Guelph, Canada
  • Employees 8
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eqcell.com
  • Social LinkedIn Facebook
  • Legal Name Eqcell Inc.
Key Metrics
  • Total Equity Funding
    $4.6M (USD)

    in 3 rounds

  • Latest Funding Round
    $855.54K (USD), Series A

    Aug 2022

  • Investors
  • Employee Count
    8

Products & Services of eQcell

eQcell offers a comprehensive portfolio of products and services, including Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells.

Equine Cord Blood Stem Cells
Stem Cell Therapy

Provides off-the-shelf treatments for equine conditions using allogeneic cells.

Canine Adipose-Derived Mesenchymal Stromal Cells
Stem Cell Therapy

Offers therapeutics for canine diseases via adipose-derived stem cells.

Funding Insights of eQcell

eQcell has successfully raised a total of $4.6M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $855.54 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.6M
  • Total Rounds 3
  • Last Round Series A β€” $855,543
  • First Round $30,000

    (Apr 2020)

  • Investors Count 2

All 3 funding rounds of eQcell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2022$855,543Series A–Ag Capital Canada
–
Dec 2021$3.71MSeries A––
–
Apr 2020$30,000Seed–Accelerator Centre
–
Valuation history

2 investors in total: 2 institutional.

Investors in eQcell

eQcell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Ag Capital Canada and Accelerator Centre.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Capital and support are provided for agricultural business growth.
–agcapitalcanada.comTillsonburg, Canada
Startups are built and accelerated in a structured studio environment.
–acceleratorcentre.comWaterloo, Canada
Premium access

Investor details for eQcell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of eQcell

1 people are tracked at eQcell (1 in leadership); the tracked headcount is 8.

NameRoleGroup
David G P Allan
Managing DirectorLeadership
Premium access

Complete people profiles for eQcell

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of eQcell

3 dated milestones of eQcell across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded eQcell is founded.
  2. Funding First funding round of $30K.
  3. Funding Latest funding round, Series A, of $856K.

Competitors of eQcell

eQcell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gallant, Bioceltix, Nupsala, J-ARM and Vetherapy, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gallant.com2018Los Angeles, United States$61.46M–
Stem cell storage for canine regenerative therapy is offered.
bioceltix.com2017Wroclaw, Poland––
Developer of drugs for veterinary therapy
nupsala.com2012Melton Mowbray, United Kingdom$192,59516
Veterinary pharmaceuticals and products are supplied alongside educational resources.
j-arm.biz2006Osaka, Japan––
Developer of lymphocyte therapy and stem cell therapy for dogs and cats
vetherapy.co2015San Francisco, United States$250,000–
Provider of stem cell therapies for pets
vetbiobank.com2011–$450,237–
Veterinary regenerative medicine
revatis.com2013Luxemburg, United States––
Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology.
actcells.com2008San Diego, United States$10.11M–
Research and development of veterinary stem cell
theracellinc.com2008Northridge, United States$1.42M–
Allograft solutions for spinal surgery are provided by TheraCell.
Premium access

Detailed competitors of eQcell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Eqcell

Premium access

Complete news archive for eQcell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to eQcell

10 companies that operate in the same segment as eQcell (Veterinary Digital Health), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Practice and prescription management software is provided for veterinary professionals.
2010Portland, Oregon, United StatesUSD 291.64 M––
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
2012Brussels, Brussels-capital Region, Belgium–––
Veterinary pharmacy services are delivered by VetSource to practices.
2005Portland, Oregon, United StatesUSD 81.25 M––
Animal health therapeutics are developed and supplied globally by Ceva.
1999Libourne, Nouvelle-aquitaine, FranceUSD 214.35 M––
Digital platform for pet insurance
2020Stockholm, SwedenUSD 114.08 M––
App based platform providing veterinary services and clinical management solutions for veterinarians
2018Beverly Hills, California, United StatesUSD 58.81 M––
Online client communication platform for veterinary doctors
2013San Diego, California, United StatesUSD 14.11 MUSD 14.38 M1
Virtual veterinary care is provided via an app platform.
2018Los Angeles, California, United StatesUSD 210 M–163
Comprehensive customer engagement platform for veterinary clinics is provided.
2015Austin, Texas, United StatesUSD 50.3 M––
Veterinary appointments are booked via an online platform.
2017Brooklyn, New York, United StatesUSD 243 M–64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about eQcell

eQcell was founded in 2010 and raised its 1st funding round 10 years after it was founded.

eQcell is headquartered in Guelph, Canada. It is registered at Guelph, Ontario, Canada.

eQcell is a funded company, having raised a total of $4.6M across 3 funding rounds to date. The company's 1st funding round was a Seed of $30K, raised on Apr 2020.

eQcell has 8 employees.

The company was founded in 2010 and is based in Guelph, Canada. Operations focus on the biotechnology sector, with emphasis on animal health. Allogeneic equine cord blood stem cells and canine adipose-derived mesenchymal stem cells are developed to offer therapeutic options. These advancements address treatments for veterinary conditions in equine and canine species.

eQcell's top competitors include Gallant, Bioceltix and Vetbiobank.

eQcell offers Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells.

eQcell has 2 investors. Key investors include Ag Capital Canada, and Accelerator Centre.

eQcell operates through Eqcell Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available